1
|
Kwizera A, Kabatooro D, Atumanya P, Tumukunde J, Kalungi J, Mwanje AK, Obua D, Agaba P, Sendagire C, Nakibuuka J, Owachi D, Dünser MW, Alenyo-Ngabirano A, Olaro C, Kyobe-Bosa H, Kirenga BJ, Nakiyingi L, Kiwanuka N, Kateete DP, Joloba M, Sewankambo N, Summers C. Respiratory Support Techniques for COVID-19-Related ARDS in a Sub-Saharan African Country: A Multicenter Observational Study. Chest 2023; 164:369-380. [PMID: 36773933 PMCID: PMC9911971 DOI: 10.1016/j.chest.2023.01.039] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2022] [Revised: 01/19/2023] [Accepted: 01/28/2023] [Indexed: 02/12/2023] Open
Abstract
BACKGROUND Limited data from low-income countries report on respiratory support techniques in COVID-19-associated ARDS. RESEARCH QUESTION Which respiratory support techniques are used in patients with COVID-19-associated ARDS in Uganda? STUDY DESIGN AND METHODS A multicenter, prospective, observational study was conducted at 13 Ugandan hospitals during the pandemic and included adults with COVID-19-associated ARDS. Patient characteristics, clinical and laboratory data, initial and most advanced respiratory support techniques, and 28-day mortality were recorded. Standard tests, log-rank tests, and logistic regression analyses were used for statistical analyses. RESULTS Four hundred ninety-nine patients with COVID-19-associated ARDS (mild, n = 137; moderate, n = 247; and severe, n = 115) were included (ICU admission, 38.9%). Standard oxygen therapy (SOX), high-flow nasal oxygen (HFNO), CPAP, noninvasive ventilation (NIV), and invasive mechanical ventilation (IMV) was used as the first-line (most advanced) respiratory support technique in 37.3% (35.3%), 10% (9.4%), 11.6% (4.8%), 23.4% (14.4%), and 17.6% (36.6%) of patients, respectively. The first-line respiratory support technique was escalated in 19.8% of patients. Twenty-eight-day mortality was 51.9% (mild ARDS, 13.1%; moderate ARDS, 62.3%; severe ARDS, 75.7%; P < .001) and was associated with respiratory support techniques as follows: SOX, 19.9%; HFNO, 31.9%; CPAP, 58.3%; NIV 61.1%; and IMV, 83.9% (P < .001). Proning was used in 79 patients (15.8%; 59 of 79 awake) and was associated with lower mortality (40.5% vs 54%; P = .03). The oxygen saturation to Fio2 ratio (OR, 0.99; 95% CI, 0.98-0.99; P < .001) and respiratory rate (OR, 1.07; 95% CI, 1.03-1.12; P = .002) at admission and NIV (OR, 6.31; 95% CI, 2.29-17.37; P < .001) or IMV (OR, 8.08; 95% CI, 3.52-18.57; P < .001) use were independent risk factors for death. INTERPRETATION SOX, HFNO, CPAP, NIV, and IMV were used as respiratory support techniques in patients with COVID-19-associated ARDS in Uganda. Although these data are observational, they suggest that the use of SOX and HFNO therapy as well as awake proning are associated with a lower mortality resulting from COVID-19-associated ARDS in a resource-limited setting.
Collapse
Affiliation(s)
- Arthur Kwizera
- Department of Anaesthesia and Critical Care, Makerere University College of Health Sciences, Kampala, Uganda.
| | - Daphne Kabatooro
- Department of Anaesthesia and Critical Care, Makerere University College of Health Sciences, Kampala, Uganda
| | - Patience Atumanya
- Department of Anaesthesia and Critical Care, Makerere University College of Health Sciences, Kampala, Uganda
| | - Janat Tumukunde
- Department of Anaesthesia and Critical Care, Makerere University College of Health Sciences, Kampala, Uganda
| | - Joyce Kalungi
- Department of Anaesthesia and Critical Care, Makerere University College of Health Sciences, Kampala, Uganda
| | - Arthur Kavuma Mwanje
- Department of Anaesthesia and Critical Care, Makerere University College of Health Sciences, Kampala, Uganda
| | - Daniel Obua
- Department of Anaesthesia and Critical Care, Makerere University College of Health Sciences, Kampala, Uganda
| | - Peter Agaba
- Department of Anaesthesia and Critical Care, Makerere University College of Health Sciences, Kampala, Uganda
| | - Cornelius Sendagire
- Department of Anaesthesia and Critical Care, Makerere University College of Health Sciences, Kampala, Uganda; Uganda Heart Institute, Kampala, Uganda
| | - Jane Nakibuuka
- Department of Medicine and Intensive Care Unit, Mulago National Referral Hospital, Kampala, Uganda
| | | | - Martin W Dünser
- Department of Anaesthesiology and Intensive Care Medicine, Kepler University Hospital and Johannes Kepler University Linz, Linz, Austria
| | | | | | - Henry Kyobe-Bosa
- Ministry of Health, Kampala, Uganda; Uganda Peoples Defence Forces, Kampala, Uganda; Kellogg College, University of Oxford, Oxford, England
| | - Bruce J Kirenga
- Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda; Makerere University Lung Institute, Kampala, Uganda
| | - Lydia Nakiyingi
- Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
| | - Noah Kiwanuka
- School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda
| | - David Patrick Kateete
- Department of Immunology and Molecular Biology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda
| | - Moses Joloba
- Department of Immunology and Molecular Biology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda
| | - Nelson Sewankambo
- Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
| | | |
Collapse
|
2
|
Kiggundu T, Ario AR, Kadobera D, Kwesiga B, Migisha R, Makumbi I, Eurien D, Kabami Z, Kayiwa J, Lubwama B, Okethwangu D, Nabadda S, Bwire G, Mulei S, Harris JR, Dirlikov E, Fitzmaurice AG, Nabatanzi S, Tegegn Y, Muruta AN, Kyabayinze D, Boore AL, Kagirita A, Kyobe-Bosa H, Mwebesa HG, Atwine D, Aceng Ocero JR. Notes from the Field: Outbreak of Ebola Virus Disease Caused by Sudan ebolavirus - Uganda, August-October 2022. MMWR Morb Mortal Wkly Rep 2022; 71:1457-1459. [PMID: 36355610 PMCID: PMC9707349 DOI: 10.15585/mmwr.mm7145a5] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 08/04/2023]
|
3
|
Kwizera A, Sendagire C, Kamuntu Y, Rutayisire M, Nakibuuka J, Muwanguzi PA, Alenyo-Ngabirano A, Kyobe-Bosa H, Olaro C. Building Critical Care Capacity in a Low-Income Country. Crit Care Clin 2022; 38:747-759. [PMID: 36162908 PMCID: PMC9507099 DOI: 10.1016/j.ccc.2022.07.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Critical illness is common throughout the world and is associated with high costs of care and resource intensity. The Corona virus disease 2019 (COVID-19) pandemic created a sudden surge of critically ill patients, which in turn led to devastating effects on health care systems worldwide and more so in Africa. This narrative report describes how an attempt was made at bridging the existing gaps in quality of care for critically ill patients at national and regional levels for COVID and the postpandemic era in a low income country.
Collapse
Affiliation(s)
- Arthur Kwizera
- Department of Anaesthesia and Critical Care, Makerere University, College of Health Sciences, Plot 1 Upper Mulago Hill Road, P O Box 2191, Kampala, Uganda,Corresponding author
| | - Cornelius Sendagire
- Department of Anaesthesia and Critical Care, Makerere University, College of Health Sciences, Plot 1 Upper Mulago Hill Road, P O Box 2191, Kampala, Uganda
| | - Yewande Kamuntu
- Clinton Health Access Initiative, Plot 8a, Moyo Close, P O Box 2191, Kampala, Uganda
| | - Meddy Rutayisire
- Department of Anaesthesia and Critical Care, Makerere University, College of Health Sciences, Plot 1 Upper Mulago Hill Road, P O Box 2191, Kampala, Uganda
| | - Jane Nakibuuka
- Department of Medicine, Intensive Care Unit, Mulago National Referral Hospital, Plot 1 Upper Mulago Hill Road, P O Box 2191, Kampala, Uganda
| | - Patience A. Muwanguzi
- Department of Nursing, College of Health Sciences, Makerere University, Plot 1 Upper Mulago Hill Road, P O Box 2191, Kampala, Uganda
| | | | - Henry Kyobe-Bosa
- Ministry of Health, Plot 6 Lourdel Road, P O Box 2191, Wandegeya, Kampala, Uganda,Uganda Peoples Defense Forces, Chwa II Road, Mbuya , P O Box 2191, Kampala, Uganda,Kellogg College, University of Oxford, 60-62 Banbury Road, Park Town, Oxford OX2 6PN, United Kingdom
| | - Charles Olaro
- Ministry of Health, Plot 6 Lourdel Road, P O Box 2191, Wandegeya, Kampala, Uganda
| |
Collapse
|
4
|
Kwagonza L, Masiira B, Kyobe-Bosa H, Kadobera D, Atuheire EB, Lubwama B, Kagirita A, Katushabe E, Kayiwa JT, Lutwama JJ, Ojwang JC, Makumbi I, Ario AR, Borchert J, Zhu BP. Outbreak of yellow fever in central and southwestern Uganda, February-may 2016. BMC Infect Dis 2018; 18:548. [PMID: 30390621 PMCID: PMC6215607 DOI: 10.1186/s12879-018-3440-y] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2018] [Accepted: 10/12/2018] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND On 28 March, 2016, the Ministry of Health received a report on three deaths from an unknown disease characterized by fever, jaundice, and hemorrhage which occurred within a one-month period in the same family in central Uganda. We started an investigation to determine its nature and scope, identify risk factors, and to recommend eventually control measures for future prevention. METHODS We defined a probable case as onset of unexplained fever plus ≥1 of the following unexplained symptoms: jaundice, unexplained bleeding, or liver function abnormalities. A confirmed case was a probable case with IgM or PCR positivity for yellow fever. We reviewed medical records and conducted active community case-finding. In a case-control study, we compared risk factors between case-patients and asymptomatic control-persons, frequency-matched by age, sex, and village. We used multivariate conditional logistic regression to evaluate risk factors. We also conducted entomological studies and environmental assessments. RESULTS From February to May, we identified 42 case-persons (35 probable and seven confirmed), of whom 14 (33%) died. The attack rate (AR) was 2.6/100,000 for all affected districts, and highest in Masaka District (AR = 6.0/100,000). Men (AR = 4.0/100,000) were more affected than women (AR = 1.1/100,000) (p = 0.00016). Persons aged 30-39 years (AR = 14/100,000) were the most affected. Only 32 case-patients and 128 controls were used in the case control study. Twenty three case-persons (72%) and 32 control-persons (25%) farmed in swampy areas (ORadj = 7.5; 95%CI = 2.3-24); 20 case-patients (63%) and 32 control-persons (25%) who farmed reported presence of monkeys in agriculture fields (ORadj = 3.1, 95%CI = 1.1-8.6); and 20 case-patients (63%) and 35 control-persons (27%) farmed in forest areas (ORadj = 3.2; 95%CI = 0.93-11). No study participants reported yellow fever vaccination. Sylvatic monkeys and Aedes mosquitoes were identified in the nearby forest areas. CONCLUSION This yellow fever outbreak was likely sylvatic and transmitted to a susceptible population probably by mosquito bites during farming in forest and swampy areas. A reactive vaccination campaign was conducted in the affected districts after the outbreak. We recommended introduction of yellow fever vaccine into the routine Uganda National Expanded Program on Immunization and enhanced yellow fever surveillance.
Collapse
Affiliation(s)
- Leocadia Kwagonza
- Uganda Public Health Fellowship Program, P.O. Box 7272, Kampala, Uganda. .,Ministry of Health of Uganda, Kampala, Uganda. .,Makerere University school of Public Health, Kampala, Uganda.
| | - Ben Masiira
- Uganda Public Health Fellowship Program, P.O. Box 7272, Kampala, Uganda.,Ministry of Health of Uganda, Kampala, Uganda.,Makerere University school of Public Health, Kampala, Uganda
| | - Henry Kyobe-Bosa
- Uganda Public Health Fellowship Program, P.O. Box 7272, Kampala, Uganda
| | - Daniel Kadobera
- Uganda Public Health Fellowship Program, P.O. Box 7272, Kampala, Uganda.,Ministry of Health of Uganda, Kampala, Uganda
| | - Emily B Atuheire
- Uganda Public Health Fellowship Program, P.O. Box 7272, Kampala, Uganda.,Ministry of Health of Uganda, Kampala, Uganda.,Makerere University school of Public Health, Kampala, Uganda
| | | | | | - Edson Katushabe
- World Health Organization, Uganda Country Office, Kampala, Uganda
| | | | | | - Joseph C Ojwang
- United States Centers for Disease Control and Prevention, Kampala, Uganda
| | | | - Alex Riolexus Ario
- Uganda Public Health Fellowship Program, P.O. Box 7272, Kampala, Uganda.,Ministry of Health of Uganda, Kampala, Uganda
| | - Jeff Borchert
- United States Centers for Disease Control and Prevention, Kampala, Uganda
| | - Bao-Ping Zhu
- United States Centers for Disease Control and Prevention, Kampala, Uganda.,Division of Global Health Protection, Center for Global Health, United States Centers for Disease Control and Prevention, Atlanta, GA, USA
| |
Collapse
|
5
|
Ippolito G, Lanini S, Brouqui P, Di Caro A, Vairo F, Abdulla S, Fusco FM, Krishna S, Capobianchi MR, Kyobe-Bosa H, Lewis DJM, Puro V, Wolfel R, Avsic-Zupanc T, Dar O, Mwaba P, Bates M, Heymann D, Zumla A. Ebola: missed opportunities for Europe-Africa research. Lancet Infect Dis 2015; 15:1254-5. [PMID: 26231479 DOI: 10.1016/s1473-3099(15)00236-4] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/03/2015] [Accepted: 07/16/2015] [Indexed: 11/24/2022]
Affiliation(s)
- Giuseppe Ippolito
- Lazzaro Spallanzani National Institute for Infectious Diseases, Via Portuense, Rome 00149, Italy.
| | - Simone Lanini
- Lazzaro Spallanzani National Institute for Infectious Diseases, Via Portuense, Rome 00149, Italy
| | - Philippe Brouqui
- Institut Hospitalo Universitaire Méditérranée Infection, Marseille, France
| | - Antonino Di Caro
- Lazzaro Spallanzani National Institute for Infectious Diseases, Via Portuense, Rome 00149, Italy
| | - Francesco Vairo
- Lazzaro Spallanzani National Institute for Infectious Diseases, Via Portuense, Rome 00149, Italy
| | | | - Francesco Maria Fusco
- Lazzaro Spallanzani National Institute for Infectious Diseases, Via Portuense, Rome 00149, Italy
| | - Sanjeev Krishna
- Institute for Infection and Immunity, St George's, University of London, London, UK
| | | | | | | | - Vincenzo Puro
- Lazzaro Spallanzani National Institute for Infectious Diseases, Via Portuense, Rome 00149, Italy
| | - Roman Wolfel
- Bundeswehr Institute of Microbiology, Munich, Germany
| | - Tatjana Avsic-Zupanc
- Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Slovenia
| | - Osman Dar
- Chatham House Centre on Global Health Security, London, UK
| | - Peter Mwaba
- UNZA-UCLMS Research and Training Project, University Teaching Hospital, Lusaka, Zambia
| | - Matthew Bates
- UNZA-UCLMS Research and Training Project, University Teaching Hospital, Lusaka, Zambia
| | - David Heymann
- Chatham House Centre on Global Health Security, London, UK
| | - Alimuddin Zumla
- UNZA-UCLMS Research and Training Project, University Teaching Hospital, Lusaka, Zambia; Division of Infection and Immunity, University College London, London, UK; NIHR Biomedical Research Centre at UCL Hospitals NHS Foundation Trust, London, UK
| |
Collapse
|